Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about James A/ Mish

Recent news which mentions James A/ Mish

22nd Century Appoints Interim CEO, Implements $15M Cost Reduction Initiative
Tickers XXII
Tags XXII Market News premium
From Benzinga
22nd Century To Secure $3M Via Registered Direct Offering Priced Above Market
Tickers XXII
Tags Benzinga James A/ Mish Cannabis
From Benzinga
22nd Century Group Q1 2023 Revenue Grows 142% YoY, What About Adjusted EBITDA?
Tickers XXII
Tags Penny Stocks Markets James A/ Mish
From Benzinga
22nd Century Group Signs Exclusive License And Distribution Agreement With Cookies
Tickers XXII
Tags News XXII premium
From Benzinga
22nd Century Group Q4 2022 Net Revenue Grows 141.3% YoY, What About Profit?
Tickers XXII
Tags Earnings News premium
From Benzinga
22nd Century Group Secures $21M Debt Financing For Accelerated Expansion
Tickers XXII
Tags Markets Penny Stocks Benzinga
From Benzinga
22nd Century Group Acquires RX Pharmatech, Files U.S. Drug Master File For CBD API, Teams Up With Transo-Pharm
Tickers XXII
Tags Penny Stocks Transo/Pharm James A/ Mish
From Benzinga
22nd Century Group's GVB Biopharma Opens New Cannabis Distribution Facility In The Netherlands
Tickers XXII
Tags Markets Penny Stocks Cannabis
From Benzinga
22nd Century Group Q3 Revenue Grows 148% YoY, Here Are The Details
Tickers XXII
Tags News Earnings XXII
From Benzinga
22nd Century Group Acquires Privately-Held Cannabis & Hemp Co., Here's What's Next
Tickers CBD HEMP XXII
Tags GVB Biopharma Market News acquisition
From Benzinga
22nd Century Group Reports Q1 Net Sales Of $9M, Up 33% YoY, Net Loss Also Grows
Tickers BAYRY XXII
Tags Markets News BAYRY
From Benzinga
FDA-Authorized Reduced-Nicotine Cigarette From 22nd Century Group That 'Helps You Smoke Less' To Reach Illinois
Tickers XXII
Tags News Market News XXII
From Benzinga
22nd Century Group To Host Q4 & FY 2021 Earnings Call
Tickers XXII
Tags Market News News Michael Zercher
From Benzinga
Aurora Cannabis, 22nd Century Group To License Biosynthesis Intellectual Property To Cronos
Tickers ACB CRON XXII
Tags cannabis intellectual property ACB Markets
From Benzinga
Cannabis Movers & Shakers: Leafly, Origin Therapeutics, ECGI Holdings, 22nd Century Group
Tickers ECGI FMANF MCMJ SPRWF
Tags ECGI FMANF XXII
From Benzinga
22nd Century Group Reports Revenue Gains In Q3, Seeks To Monetize Its Hemp & Cannabis Plant Lines
Tickers ACB XXII
Tags Markets ACB Market News
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.